Fetal malformations following progesterone therapy during pregnancy: a preliminary report

  • Johns Hopkins University ROR
  • Vanderbilt University Medical Center ROR

Fertility and Sterility, 44(1), 17-19

DOI 10.1016/s0015-0282(16)48670-x PMID 4007191

Abstract

This report presents the outcome of pregnancies of 93 women who conceived while taking progesterone (P) suppositories (n = 42) or P in oil intramuscularly (n = 51). The dosage and duration of treatment varied according to the indication. The total dose (in milligrams) increased with the duration of treatment and ranged from 75 to 13,500 mg. Two of 75 term pregnancies (2.6%) were noted to have congenital anomalies. Both women had been treated with P in oil. No patient treated with P suppositories gave birth to a malformed infant. An increased spontaneous abortion rate (28.6%) was noted among women treated with P suppositories. The authors recommend that a national registry be created to document fetal outcome after P therapy.

Topics

progesterone therapy pregnancy fetal malformation safety, progesterone suppositories intramuscular oil congenital anomalies, Rock Wentz Jones progesterone pregnancy outcomes, progesterone supplementation early pregnancy birth defects risk, luteal phase progesterone support fetal malformation rate, progesterone suppository spontaneous abortion rate pregnancy, progesterone in oil intramuscular congenital anomaly report, progesterone therapy pregnancy safety national registry, first trimester progesterone treatment teratogenicity risk, progesterone dosage duration pregnancy outcome fetal safety
PMID 4007191 4007191 DOI 10.1016/s0015-0282(16)48670-x 10.1016/s0015-0282(16)48670-x

Cite this article

Rock, J. A., Wentz, A. C., Cole, K. A., Kimball AW Jr, Zacur, H. A., Early, S. A., & Jones, G. S. (1985). Fetal malformations following progesterone therapy during pregnancy: a preliminary report. *Fertility and sterility*, *44*(1), 17-19. https://doi.org/10.1016/s0015-0282(16)48670-x

Related articles